CNC.NYSECentene CORP

Form 4: Centene Director Jessica L. Blume Reports Acquisition of Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Director Jessica L. Blume reports acquisition of 3,579 restricted stock units and indirect ownership of 250 common stock shares through a family trust.

Summary

  • Jessica L. Blume, a director of Centene Corp, filed a Form 4 detailing changes in beneficial ownership.
  • On May 13, 2025, Ms. Blume acquired 3,579 shares of restricted stock units, which will vest on the earlier of May 13, 2026, or the date of Centene's next annual meeting of stockholders.
  • The acquisition price was $0.
  • Following the transaction, Ms. Blume directly owns 28,365 shares of common stock.
  • Ms. Blume also indirectly owns 250 shares of common stock through a revocable family trust where she serves as the sole trustee.
  • Ms. Blume also owns options to buy 20,000 shares of common stock at an exercise price of $55.29, which were granted on April 24, 2021, and expire on April 24, 2028.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing indicating insider transactions. The acquisition of restricted stock units is generally a positive sign, but it's a routine event.

Positives

  • The acquisition of restricted stock units aligns the director's interests with those of the shareholders.
  • The vesting schedule encourages long-term commitment to the company's success.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting of restricted stock units in 2026 suggests a continued involvement of the director with the company.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. These filings are closely watched by investors to gauge sentiment and potential future performance.

Comparison to Industry Standards

  • Director equity ownership is a common practice in publicly traded companies like Centene (CNC).
  • Comparable companies such as UnitedHealth Group (UNH) and Anthem (ANTM) also have similar reporting requirements for their directors and officers.
  • The vesting schedules for restricted stock units are generally in line with industry standards, typically ranging from one to four years.

Stakeholder Impact

  • The acquisition of restricted stock units by a director can positively influence shareholder confidence.
  • The director's alignment with shareholder interests may encourage employees.

Next Steps

  • The restricted stock units will vest on the earlier of May 13, 2026, or the date of Centene's next annual meeting of stockholders.
  • Ms. Blume may exercise her options to purchase 20,000 shares of common stock before their expiration date on April 24, 2028.

Key Dates

DateDescription
04/24/2021Date of grant for common stock options.
04/24/2028Expiration date for common stock options.
05/13/2025Date of transaction: acquisition of restricted stock units.
05/13/2026Vesting date for restricted stock units (or earlier if annual meeting occurs before).
05/14/2025Date of signature for the Form 4 filing.

Keywords

Form 4, Beneficial Ownership, Restricted Stock Units, Centene, Director, Blume, CNC, Equity

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.